Fidelity® Dividend ETF for Rising Rates (FDRR)
37.49
-0.30 (-0.79%)
USD |
Jan 15, 20:00
Price Chart
Key Stats
Customize
| Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 0.29% | 0.19% | 316.19M | 29643.67 |
| Dividend Yield | Turnover Ratio | 1 Year Fund Level Flows | Max Drawdown (All) |
| 2.80% | 35.00% | -56.71M | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks to provide investment returns that correspond, before fees and expenses, generally to the performance of the Fidelity Dividend Index for Rising Rates℠. The fund normally invests at least 80% of assets in securities included in the underlying index and in depository receipts representing securities included in the underlying index. The underlying index is designed to reflect the performance of stocks of large and mid-capitalization dividend-paying companies that are expected to continue to pay and grow their dividends and have a positive correlation of returns to increasing 10-year U.S. Treasury yields. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Large Cap/Value |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Large Value |
| Category Index | Russell 1000 Value TR USD |
| Prospectus Objective | Growth and Income |
| Fund Owner Firm Name | Fidelity Investments |
| Prospectus Benchmark Index | |
| Fidelity Div for Rising Rates NR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Deane Gyllenhaal | 4.31 yrs |
| Louis Bottari | 4.31 yrs |
| Peter Matthew | 4.31 yrs |
| Robert Regan | 4.01 yrs |
| Payal Gupta | 1.51 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
55
-56.71M
-7.485B
Category Low
6.559B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of December 31, 2020
Performance Versus Category
As of January 15, 2021. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
Edit comparables
As of January 15, 2021.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Apple Inc | 8.19% | 127.14 | -1.37% |
| Microsoft Corp | 6.23% | 212.65 | -0.17% |
| Johnson & Johnson | 2.63% | 160.30 | -0.22% |
| UnitedHealth Group Inc | 2.51% | 351.30 | 0.22% |
| JPMorgan Chase & Co | 2.10% | 138.64 | -1.79% |
| AbbVie Inc | 2.06% | 110.52 | -0.99% |
| Qualcomm Inc | 1.97% | 157.09 | -2.34% |
| Pfizer Inc | 1.82% | 36.70 | -0.14% |
| Amgen Inc | 1.75% | 245.49 | 1.58% |
| Procter & Gamble Co | 1.73% | 134.78 | -0.75% |
News
Headline
Wire
Time (ET)
Basic Info
| Investment Strategy | |
| The investment seeks to provide investment returns that correspond, before fees and expenses, generally to the performance of the Fidelity Dividend Index for Rising Rates℠. The fund normally invests at least 80% of assets in securities included in the underlying index and in depository receipts representing securities included in the underlying index. The underlying index is designed to reflect the performance of stocks of large and mid-capitalization dividend-paying companies that are expected to continue to pay and grow their dividends and have a positive correlation of returns to increasing 10-year U.S. Treasury yields. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Large Cap/Value |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Large Value |
| Category Index | Russell 1000 Value TR USD |
| Prospectus Objective | Growth and Income |
| Fund Owner Firm Name | Fidelity Investments |
| Prospectus Benchmark Index | |
| Fidelity Div for Rising Rates NR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Deane Gyllenhaal | 4.31 yrs |
| Louis Bottari | 4.31 yrs |
| Peter Matthew | 4.31 yrs |
| Robert Regan | 4.01 yrs |
| Payal Gupta | 1.51 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (1-15-21) | 2.80% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 22.71 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of January 15, 2021
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 9/12/2016 |
| Last Annual Report Date | 7/31/2020 |
| Last Prospectus Date | 12/1/2020 |
| Attributes | |
| Enhanced Index Fund | No |
| Index Fund |
|
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |
News
Headline
Wire
Time (ET)